Sarepta Therapeutics, Inc. (SRPT)
22.18
+0.32
(+1.46%)
USD |
NASDAQ |
Dec 09, 16:00
22.10
-0.08
(-0.36%)
After-Hours: 18:09
Sarepta Therapeutics Shareholders Equity (Quarterly): 1.320B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Arrowhead Pharmaceuticals, Inc. | 466.05M |
| Amgen, Inc. | 9.619B |
| Bristol Myers Squibb Co. | 18.55B |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.493B |
| Total Liabilities (Quarterly) | 2.173B |
| Debt to Equity Ratio | 0.947 |
| Current Ratio | 2.950 |
| Net Debt Paydown Yield | 1.19% |